article_snippet.sent: A new Ebola jab is being given to people living in the West African countries most badly hit by Ebola after human trials in unaffected countries proved successful.
article_snippet.sent: A new Ebola jab is being given to people living in the West African countries most badly hit by the virus.
article_snippet.sent: Pictured: a man washes a man hands at a checkpoint in Sierra Leone's during the recent country-wide lockdown to combat Ebola virus .
article_snippet.sent: The researchers, whose findings are published in the New England Journal of Medicine, said one jab protects against a disease which has killed more than more than 10,460 people in a year across six countries including Liberia, Guinea, Sierra Leone, Nigeria, the US and Mali.
article_snippet.sent: In the phase II studies that are now beginning, the vaccine will be used in patients living in the areas currently most badly affected by Ebola, especially Guinea and Sierra Leone, but also in Liberia.
article_snippet.sent: The first case of Ebola was reported in West Africa around 15 months ago.
article_snippet.sent: According to estimates, around 25,000 people have been infected by the virus - and more than 10,000 of around 25,000 people having died since as a result.
article_snippet.sent: Corporal Anna Cross, 25, was discharged from London's Royal Free Hospital after being successfully treated for Ebola with the experimental drug MIL 77 .
highlights_snippet.sent: Ebola has killed more than 10,000 people in a year across six countries .